12.2 C
New York
Monday, June 5, 2023

Sage Therapeutics Inc. (SAGE) Is Not Likely To Be The Same Tomorrow

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Sage Therapeutics Inc. (SAGE) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.81, or 1.67%, to $49.45. The Sage Therapeutics Inc. has recorded 11,662 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

Sage Therapeutics Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $48.64 and fluctuated between $50.16 as its day high and $46.72 as its day low. The current market capitalization of Sage Therapeutics Inc. is $2.82B. A total of 1.0 million shares were traded on the day, compared to an average of 506.54K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, SAGE has seen 9 BUY and 7 SELL insider trades, representing the acquisition of 36,568 and the disposition of 18,210 shares. Over the last 12 months, there were 15 BUYs and 7 SELLs from insiders. Insiders purchased 64,974 shares during that period but sold 18,210.

In the most recent transaction, JONAS JEFFREY M sold 11,643 shares of SAGE for 44.61 per share on Feb 10. After the transaction, the Director now owns 121,981 company shares. In a previous transaction on Nov 10, Greene Barry E bought 14,500 shares at 34.48 per share. SAGE shares that President and CEO owns now total 46,940.

Among the insiders who bought shares, Golumbeski George acquired of 8,000 shares on May 05 at a per-share price of $31.45. This resulted in the Director holding 8,000 shares of SAGE after the transaction.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for SAGE in the last 3 months, the mean price target is $59.56 with high estimates of $105.00 and low estimates of $36.00. In terms of 52-week highs and lows, SAGE has a high of $50.16 and a low of $27.36.

As of this writing, SAGE has an earnings estimate of -$2.5 per share for the current quarter. EPS was calculated based on a consensus of 20 estimates, with a high estimate of -$2.05 per share and a lower estimate of -$2.86. The company reported an EPS of -$2.31 in the last quarter, which was -4.50% lower than expectations of -$2.21.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SAGE’s latest balance sheet shows that the firm has $1.74B in Cash & Short Term Investments as of fiscal 2021. There were $18.43M in debt and $85.19M in liabilities at the time. Its Book Value Per Share was $21.05, while its Total Shareholder’s Equity was $1.73B.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 21 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SAGE is Sell with a score of 3.82. A total of 11 analysts rated the stock as Buy while 0 rated it as Overweight while 10 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles